US and EU patents for innovative CellKeep™... | 22-Apr-2024 | 07:00 | RNS |
Standard form for notification of major holdings | 10-Jan-2024 | 12:57 | RNS |
Breakthrough clinical results | 04-Jan-2024 | 07:00 | RNS |
Contract announcement with Eisai Inc. | 02-Jan-2024 | 07:00 | RNS |
Broker Announcement | 11-Dec-2023 | 07:00 | RNS |
Trading and business update | 09-Nov-2023 | 07:00 | RNS |
Interim Results for the period ended 30 June 2023 | 07-Sep-2023 | 07:00 | RNS |
ANGLE notice of interim results | 15-Aug-2023 | 07:00 | RNS |
Result of 2023 Annual General Meeting | 28-Jun-2023 | 16:54 | RNS |
Standard form for notification of major holdings | 27-Jun-2023 | 12:24 | RNS |
Pharma services contract with Artios Pharma | 25-May-2023 | 07:00 | RNS |
Board change - appointment of new Chairman | 22-May-2023 | 07:00 | RNS |
Results for the year ended 31 December 2022 | 21-Apr-2023 | 07:00 | RNS |
ANGLE announces partnership with BioView | 19-Apr-2023 | 07:00 | RNS |
Pharma Services Contract with Crescendo Biologics | 13-Apr-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 12.25p |
Change Today | -0.25p |
% Change | -2.00 % |
52 Week High | 31.40 |
52 Week Low | 9.25 |
Volume | 553,192 |
Shares Issued | 260.58m |
Market Cap | £31.92m |
RiskGrade | 312 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:23 | 15,000 @ 12.30p |
16:16 | 8,100 @ 12.30p |
16:05 | 8,074 @ 12.34p |
15:26 | 8,071 @ 12.34p |
13:43 | 150 @ 12.50p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research